Common Contracts
8 similar Non-Employee Director Change of Control Agreement contracts by Biospecifics Technologies Corp
BIOSPECIFICS TECHNOLOGIES CORP. Non-Employee Director Change of Control AgreementNon-Employee Director Change of Control Agreement • March 14th, 2016 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York
This Non-Employee Director Change of Control Agreement, effective as of April 22, 2015, is entered into by and between BioSpecifics Technologies Corp., a Delaware corporation (the “Company”), with its principal offices located at 35 Wilbur Street, Lynbrook, NY 11563, and Dr. Jyrki Mattila (the “Director”).
BIOSPECIFICS TECHNOLOGIES CORP. Non-Employee Director Change of Control AgreementNon-Employee Director Change of Control Agreement • March 14th, 2016 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York
This Non-Employee Director Change of Control Agreement, effective as of April 22, 2015, is entered into by and between BioSpecifics Technologies Corp., a Delaware corporation (the “Company”), with its principal offices located at 35 Wilbur Street, Lynbrook, NY 11563, and Jennifer Chao (the “Director”).
BIOSPECIFICS TECHNOLOGIES CORP. Non-Employee Director Change of Control AgreementNon-Employee Director Change of Control Agreement • March 7th, 2014 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York
This Non-Employee Director Change of Control Agreement, effective as of September 17, 2013 is entered into by and between BioSpecifics Technologies Corp., a Delaware corporation (the “Company”), with its principal offices located at 35 Wilbur Street, Lynbrook, NY 11563, and George Gould (the “Director”).
BIOSPECIFICS TECHNOLOGIES CORP. Non-Employee Director Change of Control AgreementNon-Employee Director Change of Control Agreement • March 31st, 2009 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York
This Non-Employee Director Change of Control Agreement, effective as of October 1, 2008 is entered into by and between BioSpecifics Technologies Corp., a Delaware corporation (the "Company"), with its principal offices located at 35 Wilbur Street, Lynbrook, NY 11563, and Matthew Geller (the "Director").
BIOSPECIFICS TECHNOLOGIES CORP. Non-Employee Director Change of Control AgreementNon-Employee Director Change of Control Agreement • September 26th, 2007 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York
This Non-Employee Director Change of Control Agreement, effective as of June 18, 2007 is entered into by and between BioSpecifics Technologies Corp., a Delaware corporation (the “Company”), with its principal offices located at 35 Wilbur Street, Lynbrook, NY 11563, and Michael Schamroth (the “Director”).
BIOSPECIFICS TECHNOLOGIES CORP. Non-Employee Director Change of Control AgreementNon-Employee Director Change of Control Agreement • September 26th, 2007 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York
This Non-Employee Director Change of Control Agreement, effective as of June 18, 2007 is entered into by and between BioSpecifics Technologies Corp., a Delaware corporation (the “Company”), with its principal offices located at 35 Wilbur Street, Lynbrook, NY 11563, and Paul Gitman (the “Director”).
BIOSPECIFICS TECHNOLOGIES CORP. Non-Employee Director Change of Control AgreementNon-Employee Director Change of Control Agreement • September 26th, 2007 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York
This Non-Employee Director Change of Control Agreement, effective as of June 18, 2007 is entered into by and between BioSpecifics Technologies Corp., a Delaware corporation (the “Company”), with its principal offices located at 35 Wilbur Street, Lynbrook, NY 11563, and Henry Morgan (the “Director”).
BIOSPECIFICS TECHNOLOGIES CORP. Non-Employee Director Change of Control AgreementNon-Employee Director Change of Control Agreement • June 22nd, 2007 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York
This Non-Employee Director Change of Control Agreement, effective as of June ___, 2007 is entered into by and between BioSpecifics Technologies Corp., a Delaware corporation (the “Company”), with its principal offices located at 35 Wilbur Street, Lynbrook, NY 11563, and ___________ (the “Director”).
